DK0680470T3 - - Google Patents
Info
- Publication number
- DK0680470T3 DK0680470T3 DK94906446.3T DK94906446T DK0680470T3 DK 0680470 T3 DK0680470 T3 DK 0680470T3 DK 94906446 T DK94906446 T DK 94906446T DK 0680470 T3 DK0680470 T3 DK 0680470T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- sec
- date
- tumors
- pub
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US656993A | 1993-01-21 | 1993-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0680470T3 true DK0680470T3 (de) | 1997-04-28 |
Family
ID=21721516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94906446.3T DK0680470T3 (de) | 1993-01-21 | 1993-12-17 |
Country Status (20)
Country | Link |
---|---|
US (1) | US5648365A (de) |
EP (1) | EP0680470B1 (de) |
JP (1) | JP3398748B2 (de) |
KR (1) | KR100377280B1 (de) |
AT (1) | ATE150748T1 (de) |
AU (1) | AU679723B2 (de) |
CA (1) | CA2152794C (de) |
DE (1) | DE69309310T2 (de) |
DK (1) | DK0680470T3 (de) |
ES (1) | ES2102830T3 (de) |
FI (1) | FI112474B (de) |
GR (1) | GR3023188T3 (de) |
HU (1) | HUT72078A (de) |
IL (1) | IL108369A (de) |
MX (1) | MX9400563A (de) |
NO (1) | NO305166B1 (de) |
NZ (1) | NZ261414A (de) |
TW (1) | TW243445B (de) |
WO (1) | WO1994017040A1 (de) |
ZA (1) | ZA94317B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ249040A (en) * | 1992-02-06 | 1997-06-24 | Merrell Dow Pharma | Triphenyl azacycloalkane derivatives; treatment of drug resistance |
AU6366000A (en) * | 1999-07-23 | 2001-02-13 | Colorado State University Research Foundation | Multidrug resistance pump inhibitors and uses thereof |
US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
EP1451856A2 (de) * | 2001-11-07 | 2004-09-01 | Pharmacia Corporation | Verfahren zur förderung der aufnahme und kernakkumulation von polyamiden in eukaryotischen zellen |
US8153184B2 (en) * | 2001-11-26 | 2012-04-10 | Samsung Mobile Display Co., Ltd. | Organic EL display device and method of manufacturing the same |
KR100656490B1 (ko) | 2001-11-26 | 2006-12-12 | 삼성에스디아이 주식회사 | 풀칼라 유기전계 발광표시소자 및 그의 제조방법 |
WO2014124209A1 (en) | 2013-02-08 | 2014-08-14 | General Mills, Inc. | Reduced sodium food products |
CN110372571B (zh) * | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1049377B (de) * | 1952-04-03 | 1959-01-29 | Abbott Laboratories, North Chicago, 111. (V. St. A.) | Verfahren zur Herstellung von substituierten Vinylpiperidinen |
US2898339A (en) * | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
US3956296A (en) * | 1974-12-11 | 1976-05-11 | A. H. Robins Company, Incorporated | 1-Substituted-4-benzylpiperidines |
US4035372A (en) * | 1976-08-13 | 1977-07-12 | G. D. Searle & Co. | 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines |
EP0228893A3 (de) * | 1985-12-20 | 1990-01-03 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | Durch Aryloxyalkyl-Gruppen N-substituierte Arylalkyl heterozyklische Amine in Allergieheilverfahren |
US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
US4990511A (en) * | 1988-08-03 | 1991-02-05 | Takeda Chemical Industries, Ltd. | Amide compounds, their production and use |
DK0409406T3 (da) * | 1989-06-19 | 1994-02-07 | Wellcome Found | Arylsubstituerede aminderivater, der er anvendelige ved cancerterapi |
GB9000305D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Anticholinergic agents |
EP0467435A3 (en) * | 1990-07-19 | 1992-04-01 | Akzo N.V. | Benzhydryl derivatives having calmodulin inhibitor properties |
DK0471612T3 (da) * | 1990-08-14 | 1999-02-22 | Hoechst Marion Roussel Inc | Nye 19-nor steroider med carbonkæde omfattende en amidgruppe i 11-beta-stillingen, fremgangsmåde til deres fremstilling, de |
NZ249040A (en) * | 1992-02-06 | 1997-06-24 | Merrell Dow Pharma | Triphenyl azacycloalkane derivatives; treatment of drug resistance |
-
1993
- 1993-12-17 US US08/481,538 patent/US5648365A/en not_active Expired - Fee Related
- 1993-12-17 KR KR1019950702950A patent/KR100377280B1/ko not_active IP Right Cessation
- 1993-12-17 NZ NZ261414A patent/NZ261414A/en unknown
- 1993-12-17 ES ES94906446T patent/ES2102830T3/es not_active Expired - Lifetime
- 1993-12-17 JP JP51701194A patent/JP3398748B2/ja not_active Expired - Fee Related
- 1993-12-17 EP EP94906446A patent/EP0680470B1/de not_active Expired - Lifetime
- 1993-12-17 CA CA002152794A patent/CA2152794C/en not_active Expired - Fee Related
- 1993-12-17 AU AU60148/94A patent/AU679723B2/en not_active Ceased
- 1993-12-17 HU HU9502195A patent/HUT72078A/hu unknown
- 1993-12-17 DE DE69309310T patent/DE69309310T2/de not_active Expired - Fee Related
- 1993-12-17 WO PCT/US1993/012300 patent/WO1994017040A1/en active IP Right Grant
- 1993-12-17 AT AT94906446T patent/ATE150748T1/de not_active IP Right Cessation
- 1993-12-17 DK DK94906446.3T patent/DK0680470T3/da active
-
1994
- 1994-01-17 ZA ZA94317A patent/ZA94317B/xx unknown
- 1994-01-18 TW TW083100396A patent/TW243445B/zh active
- 1994-01-19 IL IL10836994A patent/IL108369A/en not_active IP Right Cessation
- 1994-01-20 MX MX9400563A patent/MX9400563A/es not_active IP Right Cessation
-
1995
- 1995-07-20 NO NO952885A patent/NO305166B1/no not_active IP Right Cessation
- 1995-07-20 FI FI953506A patent/FI112474B/fi active
-
1997
- 1997-04-21 GR GR970400848T patent/GR3023188T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
MX9400563A (es) | 1994-07-29 |
JP3398748B2 (ja) | 2003-04-21 |
DE69309310T2 (de) | 1997-11-06 |
NO305166B1 (no) | 1999-04-12 |
EP0680470B1 (de) | 1997-03-26 |
ES2102830T3 (es) | 1997-08-01 |
FI953506A (fi) | 1995-07-20 |
FI112474B (fi) | 2003-12-15 |
NZ261414A (en) | 1997-06-24 |
KR100377280B1 (ko) | 2003-07-18 |
NO952885D0 (no) | 1995-07-20 |
HU9502195D0 (en) | 1995-09-28 |
TW243445B (de) | 1995-03-21 |
HUT72078A (en) | 1996-03-28 |
FI953506A0 (fi) | 1995-07-20 |
IL108369A0 (en) | 1994-04-12 |
EP0680470A1 (de) | 1995-11-08 |
KR960700230A (ko) | 1996-01-19 |
GR3023188T3 (en) | 1997-07-30 |
ATE150748T1 (de) | 1997-04-15 |
WO1994017040A1 (en) | 1994-08-04 |
US5648365A (en) | 1997-07-15 |
DE69309310D1 (de) | 1997-04-30 |
NO952885L (no) | 1995-09-20 |
CA2152794A1 (en) | 1994-08-04 |
IL108369A (en) | 1999-08-17 |
AU6014894A (en) | 1994-08-15 |
JPH08505870A (ja) | 1996-06-25 |
CA2152794C (en) | 1999-04-06 |
ZA94317B (en) | 1994-08-18 |
AU679723B2 (en) | 1997-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5454894A (en) | Pyrazoles having CRF antagonist activity | |
TW285667B (de) | ||
SG55184A1 (en) | New imidazopyridines | |
TW243445B (de) | ||
AU2797695A (en) | Thiazolidine derivatives, their preparation and drugs containing same | |
EP0730581A4 (de) | 3-acylaminobenzazepine | |
TW226330B (de) | ||
TW251283B (de) | ||
AU3809095A (en) | 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives | |
TW224461B (de) | ||
EP0641346A1 (de) | Antibiotische 7-aminonaphthazarinderivate. | |
ATE170850T1 (de) | Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung |